Archive for February 2022
Gelesis cuts contractors after SPAC investors pull out: report
Gelesis has axed 140 contractors from Boston firm Syneos Health who had been hired to pitch Plenity to doctors, after SPAC investors pulled out of the deal. Read More
Read MoreSigns your star employee might be a turnover threat — and what to do about it.
Here are some red flags that can help identify turnover threats for your star performers — and how employers can step in. Read More
Read MoreBlack restaurateurs call for more relief funding as pandemic drags on
Black restaurateurs outside the State House said they have had difficulty securing aid dollars and called on the state to dish out more money to help them survive. Read More
Read MoreThis exec leads the only city-owned college in the U.S.
Quincy College is the only college in the U.S. owned by a city. The Business Journal spoke with its president, Rick DeCristofaro. Read More
Read MoreBiologics startup to go public in reverse merger
Despite a major slowdown in the public markets, a Woburn-based biologics startup is slated to go public via a reverse merger with a special-purpose acquisition company, better known as a SPAC. Read More
Read MoreLabs proposed for BPDA-approved, never-built South End office project
Boston developer Ron Druker says he’s making the pivot, eight years after city approval, in response to the surge in demand for life sciences space. Read More
Read MoreCybereason confidentially files for U.S. IPO, report says
Cybereason Inc., which last year outlined IPO plans following a $275 million fundraise, may be one of the first local tech companies to go public in 2022. Read More
Read MoreStartup’s personality quiz pairs people with greeting cards
The startup has come a long way since 2020 when co-founder Ekaterina Taunova began experimenting with an idea for a greeting card business. Read More
Read MoreBostInno Approved: Here are the February events you need to know about
Check out the local business events this February, including Harvard Business School’s venture capital conference. Read More
Read More‘A huge unmet need’: Takeda-owned startup focuses on premature babies
The new biotech startup has launched with drugs licensed from Takeda Pharmaceutical Co., which also has an ownership stake in the company. Read More
Read More